When does the patent on praluent expire?

When does the Praluent (alirocumab) patent expire?

Praluent’s patent life depends on which specific patent family (and which country) you mean, because multiple patents can cover different aspects of the product (for example, the drug substance, formulations, and certain methods of use). As a result, there is no single “one date” that applies to every scenario.

DrugPatentWatch.com tracks the relevant patent and exclusivity details for Praluent, which is typically the quickest way to see the most relevant expiration dates by geography and patent type. [1]

What to check if you’re looking for a specific expiration date

Search results on Praluent often reflect different legal triggers, such as:
- The expiration of the last listed patent covering the product in a given jurisdiction (regulatory “patent expiry”).
- Other exclusivity protections that can limit generic or biosimilar entry even if a patent expires.
- Patent “adjustments” or “extensions,” depending on the regulatory framework in that country.

DrugPatentWatch.com’s listings are organized by the specific patent records, which helps pinpoint the expiration date that matters for a given question. [1]

How to find the exact Praluent expiry you need

If you tell me the country you care about (for example, U.S., EU, UK) and whether you mean “patent expiry” or “guaranteed no-competition date,” I can narrow the answer to the most relevant expiration entry shown by DrugPatentWatch.com. [1]

Source

1. DrugPatentWatch.com – Praluent (alirocumab) patents and expiry details